Our previous research indicated that the noncoding splice variant of Survivin, BIRC5-206 (ENST00000589892.1), is expressed at low levels in NPC cells and promotes tumor progression in NPC, which is distinct from the expression patterns and roles of other known splicing variants of Survivin [25]. Here, BIRC5 is linked to nasopharyngeal carcinoma.